0 31/07/2023 2023-07-31 false false false false false false false false false false true false false true false false false false false false false No description of principal activities is disclosed 2022-08-01 Sage Accounts Production 21.0 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 12757122 2022-08-01 2023-07-31 12757122 2023-07-31 12757122 2022-07-31 12757122 bus:RegisteredOffice 2022-08-01 2023-07-31 12757122 bus:LeadAgentIfApplicable 2022-08-01 2023-07-31 12757122 bus:Director1 2022-08-01 2023-07-31 12757122 bus:Director2 2022-08-01 2023-07-31 12757122 bus:Director3 2022-08-01 2023-07-31 12757122 core:WithinOneYear 2023-07-31 12757122 core:WithinOneYear 2022-07-31 12757122 core:ShareCapital 2023-07-31 12757122 core:ShareCapital 2022-07-31 12757122 core:RetainedEarningsAccumulatedLosses 2023-07-31 12757122 core:RetainedEarningsAccumulatedLosses 2022-07-31 12757122 bus:SmallEntities 2022-08-01 2023-07-31 12757122 bus:AuditExemptWithAccountantsReport 2022-08-01 2023-07-31 12757122 bus:FullAccounts 2022-08-01 2023-07-31 12757122 bus:SmallCompaniesRegimeForAccounts 2022-08-01 2023-07-31 12757122 bus:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31
Company registration number: 12757122
Imperial Medical Solutions Limited
Unaudited filleted financial statements
31 July 2023
Imperial Medical Solutions Limited
Contents
Directors and other information
Accountants report
Statement of financial position
Notes to the financial statements
Imperial Medical Solutions Limited
Directors and other information
Directors Dr R Senasi
Mr T H A Arulampalam
Mr A Haq
Company number 12757122
Registered office Exchange Building
66 Church Street
Hartlepool
TS24 7DN
Accountants Censis
Exchange Building
66 Church Street
Hartlepool
TS24 7DN
Imperial Medical Solutions Limited
Chartered accountants report to the board of directors on the preparation of the
unaudited statutory financial statements of Imperial Medical Solutions Limited
Year ended 31 July 2023
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the financial statements of Imperial Medical Solutions Limited for the year ended 31 July 2023 which comprise the statement of financial position and related notes from the company's accounting records and from information and explanations you have given us.
As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com /en/members/regulations-standards-and-guidance/.
This report is made solely to the board of directors of Imperial Medical Solutions Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the financial statements of Imperial Medical Solutions Limited and state those matters that we have agreed to state to the board of directors of Imperial Medical Solutions Limited as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Imperial Medical Solutions Limited and its board of directors as a body for our work or for this report.
It is your duty to ensure that Imperial Medical Solutions Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and loss of Imperial Medical Solutions Limited. You consider that Imperial Medical Solutions Limited is exempt from the statutory audit requirement for the year.
We have not been instructed to carry out an audit or a review of the financial statements of Imperial Medical Solutions Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.
Censis
Chartered Accountants
Exchange Building
66 Church Street
Hartlepool
TS24 7DN
12 March 2024
Imperial Medical Solutions Limited
Statement of financial position
31 July 2023
2023 2022
Note £ £ £ £
Current assets
Cash at bank and in hand 862 2,260
_______ _______
862 2,260
Creditors: amounts falling due
within one year 4 ( 6,150) ( 5,310)
_______ _______
Net current liabilities ( 5,288) ( 3,050)
_______ _______
Total assets less current liabilities ( 5,288) ( 3,050)
_______ _______
Net liabilities ( 5,288) ( 3,050)
_______ _______
Capital and reserves
Called up share capital 100 100
Profit and loss account ( 5,388) ( 3,150)
_______ _______
Shareholders deficit ( 5,288) ( 3,050)
_______ _______
For the year ending 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 12 March 2024 , and are signed on behalf of the board by:
Dr R Senasi
Director
Company registration number: 12757122
Imperial Medical Solutions Limited
Notes to the financial statements
Year ended 31 July 2023
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Exchange Building, 66 Church Street, Hartlepool, TS24 7DN.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
These financial statements have been prepared in compliance with FRS 105 Micro Entities , 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Turnover
Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.
Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
4. Creditors: amounts falling due within one year
2023 2022
£ £
Other creditors 6,150 5,310
_______ _______